Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis.
作者信息
Lee Chang Hun, Kim In Hee
机构信息
Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea.
出版信息
Gut Liver. 2021 Jul 15;15(4):490-491. doi: 10.5009/gnl210296.
Abstract
摘要
相似文献
1
Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis.直接胆红素血症作为肝硬化患者死亡率的预测指标
Gut Liver. 2021 Jul 15;15(4):490-491. doi: 10.5009/gnl210296.
2
Bile Cast Nephropathy in Cirrhotic Patients: Effects of Chronic Hyperbilirubinemia.肝硬化患者的胆汁管型肾病：慢性高胆红素血症的影响
Am J Clin Pathol. 2017 May 1;147(5):525-535. doi: 10.1093/ajcp/aqx030.
3
Cirrhosis and fetal hyperbilirubinemia.
Obstet Gynecol. 1981 Jun;57(6 Suppl):25S-7S.
4
Indirect reacting hyperbilirubinemia in cirrhosis: its relation to red cell survival.肝硬化中的间接反应性高胆红素血症：其与红细胞存活的关系。
Am J Dig Dis. 1968 Jul;13(7):598-607. doi: 10.1007/BF02232966.
5
Increased regulatory T cells in patients with liver cirrhosis correlated with hyperbilirubinemia and predict bacterial complications.肝硬化患者体内调节性T细胞增加与高胆红素血症相关，并可预测细菌感染并发症。
J Gastroenterol Hepatol. 2015 Apr;30(4):775-83. doi: 10.1111/jgh.12781.
6
Hyperbilirubinemia in the patient past 50.50岁以上患者的高胆红素血症。
Geriatrics. 1967 Mar;22(3):206-12.
7
Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.白蛋白透析治疗合并急性肝损伤的肝硬化：一项前瞻性对照研究。
Hepatology. 2002 Oct;36(4 Pt 1):949-58. doi: 10.1053/jhep.2002.36130.
8
[Fasting hyperbilirubinemia. A test for diagnosis of Gilbert's syndrome or a physiological phenomenon?].
Dtsch Med Wochenschr. 1973 Sep 14;98(37):1704-6 passim. doi: 10.1055/s-0028-1107112.
9
Hyperbilirubinemia following distal splenorenal shunt.
Arch Surg. 1985 Mar;120(3):301-5. doi: 10.1001/archsurg.1985.01390270041008.
10
Mild hyperbilirubinemia as a marker of oesophageal varices in HCV-related compensated cirrhotic patients.轻度高胆红素血症作为丙型肝炎病毒相关性代偿期肝硬化患者食管静脉曲张的标志物
Pol Merkur Lekarski. 2019 May 27;46(275):209-212.
引用本文的文献
1
Therapeutic effect of notoginseng saponins before and after fermentation on blood deficiency rats.三七皂苷发酵前后对血虚大鼠的治疗作用
Exp Ther Med. 2024 Feb 15;27(4):143. doi: 10.3892/etm.2024.12431. eCollection 2024 Apr.
本文引用的文献
1
Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis.直接胆红素比总胆红素更能预测肝硬化患者的预后。
Gut Liver. 2021 Jul 15;15(4):599-605. doi: 10.5009/gnl20171.
2
Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis.液体生物标志物预测肝硬化预后。
Biomed Res Int. 2020 Mar 20;2020:7170457. doi: 10.1155/2020/7170457. eCollection 2020.
3
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
4
Hepatocyte senescence explains conjugated bilirubinaemia in chronic liver failure.肝细胞衰老可解释慢性肝衰竭中的结合胆红素血症。
J Hepatol. 2015 Aug;63(2):532-3. doi: 10.1016/j.jhep.2015.03.031. Epub 2015 Apr 1.
5
6
Assessment of prognosis of cirrhosis.肝硬化预后评估。
Semin Liver Dis. 2008 Feb;28(1):110-22. doi: 10.1055/s-2008-1040325.
7
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.肝静脉压力梯度可预测代偿期肝硬化患者的临床失代偿情况。
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
8
The model for end-stage liver disease (MELD).终末期肝病模型（MELD）
Hepatology. 2007 Mar;45(3):797-805. doi: 10.1002/hep.21563.
9
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.肝硬化患者生存的自然史及预后指标：118项研究的系统评价
J Hepatol. 2006 Jan;44(1):217-31. doi: 10.1016/j.jhep.2005.10.013. Epub 2005 Nov 9.
10
[Bilirubin metabolism in liver cirrhosis].
Nihon Rinsho. 1994 Jan;52(1):138-44.
Zotero 插件